1. Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019
   Sarah Krieg et al, 2022, Cancers CrossRef
2. Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
   Khalid I. Bzeizi et al, 2021, Cancers CrossRef
3. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
   Hee Chul Nam et al, 2016, World Journal of Gastroenterology CrossRef
4. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
   Antonio Facciorusso, 2015, World Journal of Hepatology CrossRef
5. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
   Isabelle Mohr et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
6. The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
   Tao Han et al, 2019, BioScience Trends CrossRef
7. Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment
   Lior Charach et al, 2017, EMJ Hepatology CrossRef
8. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma
   Yang Jun Kang et al, 2020, CardioVascular and Interventional Radiology CrossRef
9. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
   Antonio Facciorusso, 2018, World Journal of Gastroenterology CrossRef